Gastrinoma
Also known as: Gastrinoma (disorder) / Gastrinoma (morphologic abnormality)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00085 | Pancrelipase | A purified form of porcine pancreatic lipase, amylase, and protease enzymes used to treat malabsorption associated with pancreatic insufficiency resulting from cystic fibrosis and pancreatitis. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00085 | Pancrelipase | Dietary fat | target |
| DB00085 | Pancrelipase | Dietary protein | target |
| DB00085 | Pancrelipase | Dietary starch | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00958 | Carboplatin | 1 | Completed | 1 |
| DB15631 | Edodekin alfa | 1 | Completed | 1 |
| DB01590 | Everolimus | 1 | Completed | 1 |
| DB15721 | Natural Killer Cell | 1 | Completed | 1 |
| DB01229 | Paclitaxel | 1 | Completed | 1 |
| DB00072 | Trastuzumab | 1 | Completed | 1 |
| DB04879 | Vatalanib | 1 | Completed | 1 |
| DB00112 | Bevacizumab | 2 | Completed | 1 |
| DB01101 | Capecitabine | 2 | Active Not Recruiting | 1 |
| DB01101 | Capecitabine | 2 | Completed | 1 |
| DB05928 | Dovitinib | 2 | Withdrawn | 1 |
| DB17969 | Edotreotide | 2 | Withdrawn | 1 |
| DB01590 | Everolimus | 2 | Terminated | 2 |
| DB00317 | Gefitinib | 2 | Completed | 1 |
| DB13982 | Lutetium Lu-177 | 2 | Withdrawn | 1 |
| DB00338 | Omeprazole | 2 | Completed | 1 |
| DB00213 | Pantoprazole | 2 | Completed | 1 |
| DB08896 | Regorafenib | 2 | Completed | 1 |
| DB06176 | Romidepsin | 2 | Terminated | 1 |
| DB00398 | Sorafenib | 2 | Completed | 1 |
| DB00853 | Temozolomide | 2 | Active Not Recruiting | 1 |
| DB00853 | Temozolomide | 2 | Completed | 1 |
| DB00135 | Tyrosine | 2 | Withdrawn | 1 |